66 related articles for article (PubMed ID: 21575849)
1. Mid-follicular LH supplementation in women aged 35-39 years undergoing ICSI cycles: a randomized controlled study.
Matorras R; Prieto B; Exposito A; Mendoza R; Crisol L; Herranz P; Burgués S
Reprod Biomed Online; 2011 Feb; 22 Suppl 1():S43-51. PubMed ID: 21575849
[TBL] [Abstract][Full Text] [Related]
2. Mid-follicular LH supplementation in women aged 35-39 years undergoing ICSI cycles: a randomized controlled study.
Matorras R; Prieto B; Exposito A; Mendoza R; Crisol L; Herranz P; Burgués S
Reprod Biomed Online; 2009 Dec; 19(6):879-87. PubMed ID: 20031032
[TBL] [Abstract][Full Text] [Related]
3. The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study.
Tarlatzis B; Tavmergen E; Szamatowicz M; Barash A; Amit A; Levitas E; Shoham Z
Hum Reprod; 2006 Jan; 21(1):90-4. PubMed ID: 16172149
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment.
Marrs R; Meldrum D; Muasher S; Schoolcraft W; Werlin L; Kelly E
Reprod Biomed Online; 2004 Feb; 8(2):175-82. PubMed ID: 14989794
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human LH supplementation versus supplementation with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol: a matched case-control study.
Bühler KF; Fischer R
Gynecol Endocrinol; 2012 May; 28(5):345-50. PubMed ID: 22115012
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of recombinant versus human derived follicle stimulating hormone on the oocyte and embryo quality in IVF-ICSI cycles: Randomised, controlled, multi-centre trial.
Abate A; Nazzaro A; Salerno A; Marzano F; Pavone Cossut MR; Perino M
Gynecol Endocrinol; 2009 Aug; 25(8):479-84. PubMed ID: 19572228
[TBL] [Abstract][Full Text] [Related]
7. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates.
Lahoud R; Al-Jefout M; Tyler J; Ryan J; Driscoll G
Hum Reprod; 2006 Oct; 21(10):2645-9. PubMed ID: 16785261
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation.
Durnerin CI; Erb K; Fleming R; Hillier H; Hillier SG; Howles CM; Hugues JN; Lass A; Lyall H; Rasmussen P; Thong J; Traynor I; Westergaard L; Yates R;
Hum Reprod; 2008 Feb; 23(2):421-6. PubMed ID: 18084048
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age.
Fábregues F; Creus M; Peñarrubia J; Manau D; Vanrell JA; Balasch J
Fertil Steril; 2006 Apr; 85(4):925-31. PubMed ID: 16580376
[TBL] [Abstract][Full Text] [Related]
10. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures.
Ruvolo G; Bosco L; Pane A; Morici G; Cittadini E; Roccheri MC
Fertil Steril; 2007 Mar; 87(3):542-6. PubMed ID: 17126339
[TBL] [Abstract][Full Text] [Related]
11. Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression.
Cavagna M; Maldonado LG; de Souza Bonetti TC; de Almeida Ferreira Braga DP; Iaconelli A; Borges E
Fertil Steril; 2010 Jun; 94(1):167-72. PubMed ID: 19342035
[TBL] [Abstract][Full Text] [Related]
12. [A prospective, randomized controlled study comparing the effects of gonadotropin-releasing hormone agonist long and short protocols for in vitro fertilization].
Ye H; Huang G; Pei L
Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):222-5. PubMed ID: 11783366
[TBL] [Abstract][Full Text] [Related]
13. [Oocyte and embryo quality and outcome of ICSI cycles in patients with polycystic ovary syndrome (PCOS) versus normo-ovulatory].
Kdous M; Chaker A; Zhioua A; Zhioua F
J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):133-43. PubMed ID: 19179017
[TBL] [Abstract][Full Text] [Related]
14. Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment--recombinant HCG versus urinary HCG. The European Recombinant Human Chorionic Gonadotrophin Study Group.
Hum Reprod; 2000 Jul; 15(7):1446-51. PubMed ID: 10875887
[TBL] [Abstract][Full Text] [Related]
15. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Papaleo E; Unfer V; Baillargeon JP; Fusi F; Occhi F; De Santis L
Fertil Steril; 2009 May; 91(5):1750-4. PubMed ID: 18462730
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.
De Placido G; Alviggi C; Perino A; Strina I; Lisi F; Fasolino A; De Palo R; Ranieri A; Colacurci N; Mollo A;
Hum Reprod; 2005 Feb; 20(2):390-6. PubMed ID: 15576390
[TBL] [Abstract][Full Text] [Related]
17. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.
Lehert P; Kolibianakis EM; Venetis CA; Schertz J; Saunders H; Arriagada P; Copt S; Tarlatzis B
Reprod Biol Endocrinol; 2014 Feb; 12():17. PubMed ID: 24555766
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count.
Jayaprakasan K; Hopkisson J; Campbell B; Johnson I; Thornton J; Raine-Fenning N
BJOG; 2010 Jun; 117(7):853-62. PubMed ID: 20353458
[TBL] [Abstract][Full Text] [Related]
20. Establishing a combined stimulation protocol hFSH followed by rFSH might represent a breakthrough in the IVF practice.
Gerli S; Di Renzo GC
Eur Rev Med Pharmacol Sci; 2013; 17(15):2091-6. PubMed ID: 23884831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
